Your session is about to expire
← Back to Search
Intervention for Spinal Injury
Study Summary
This trial is designed to study whether tranexamic acid can reduce blood loss in patients who have sustained a spine injury requiring surgery. The study will last for two years and will compare outcomes in patients who receive tranexamic acid to those who receive a placebo.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How can I sign up to participate in this research?
"Spinal injury patients that are between 18-80 years old may qualify for this trial. Right now, the clinical study has 252 open slots for participants."
Is this study looking for more test subjects at the moment?
"The clinicaltrials.gov website says that this trial is still looking for volunteers. The study was first posted on June 15th 2020, with the most recent update taking place on March 7th 2022."
What is the main reason that people are given this Intervention medication?
"Intervention is an effective medical treatment for hyperfibrinolysis, hemophilia, and other bleeding disorders."
Are there historical examples of Intervention's efficacy in a medical setting?
"The intervention was first studied in 2010 Guangzhou TCM University. As of right now, a total of 18468 studies have been completed. Out of the 68 active trials, many are taking place Durham, North carolina."
Is this study currently enrolling patients who are over the age of 50?
"As this study is only open to applicants aged 18-80, there are 67 other trials that might be more appropriate for minors and 385 studies better suited for senior citizens."
Is this study widely available to patients in the United States?
"There are several locations where this trial is accepting patients, some of which include Duke University Medical Center in Durham, North carolina as well as Norton Leatherman Spine Center in Louisville, Kentucky."
How many individuals are presently enrolled in this trial?
"252 patients that fit the given inclusion criteria are needed to enroll at various sites, such as Duke University Medical Center and Norton Leatherman Spine Center."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger